Cargando…

Correction: Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion

Detalles Bibliográficos
Autores principales:	Choi, Yeon Ja, Park, Yun Jung, Park, Ji Young, Jeong, Hyoung Oh, Kim, Dae Hyun, Ha, Young Mi, Kim, Ji Min, Song, Yu Min, Heo, Hyoung-Sam, Yu, Byung Pal, Chun, Pusoon, Moon, Hyung Ryong, Chung, Hae Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567894/ http://dx.doi.org/10.1371/annotation/e3163ad5-f3d8-4a21-b3e1-f2033a76f9db

Ejemplares similares

Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion
por: Choi, Yeon Ja, et al.
Publicado: (2012)

Inhibition of Mast Cell Function and Proliferation by mTOR Activator MHY1485
por: Rakhmanova, Valeriya, et al.
Publicado: (2018)

MHY1485 ameliorates UV-induced skin cell damages via activating mTOR-Nrf2 signaling
por: Yang, Bo, et al.
Publicado: (2017)

The Efficacy and Safety of the mTOR Signaling Pathway Activator, MHY1485, for in vitro Activation of Human Ovarian Tissue
por: Wu, Shuang, et al.
Publicado: (2021)

Potent Anti-Diabetic Effects of MHY908, a Newly Synthesized PPAR α/γ Dual Agonist in db/db Mice
por: Park, Min Hi, et al.
Publicado: (2013)

MHY1485 enhances X-irradiation-induced apoptosis and senescence in tumor cells
por: Sun, Lue, et al.
Publicado: (2021)

The Novel PPAR α/γ Dual Agonist MHY 966 Modulates UVB–Induced Skin Inflammation by Inhibiting NF-κB Activity
por: Park, Min Hi, et al.
Publicado: (2013)

Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013)
por: An, Hye Jin, et al.
Publicado: (2017)

Correction: Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013)
por: An, Hye Jin, et al.
Publicado: (2017)

PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling
por: Kim, Min Jo, et al.
Publicado: (2021)

A new SIRT1 inhibitor, MHY2245, induces autophagy and inhibits energy metabolism via PKM2/mTOR pathway in human ovarian cancer cells
por: Tae, In Hwan, et al.
Publicado: (2020)

Hepatoprotective Effects of MHY3200 on High-Fat, Diet-Induced, Non-Alcoholic Fatty Liver Disease in Rats
por: Kim, Min Jo, et al.
Publicado: (2018)

Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging
por: Kim, Seong Min, et al.
Publicado: (2017)

Pro-apoptotic effect of the novel benzylidene derivative MHY695 in human colon cancer cells
por: Heo, Gwangbeom, et al.
Publicado: (2019)

mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014)

Thiobarbiturate-Derived Compound MHY1025 Alleviates Renal Fibrosis by Modulating Oxidative Stress, Epithelial Inflammation, and Fibroblast Activation
por: Kim, Jeongwon, et al.
Publicado: (2023)

Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair
por: Park, Ji Hye, et al.
Publicado: (2021)

PPAR Pan Agonist MHY2013 Alleviates Renal Fibrosis in a Mouse Model by Reducing Fibroblast Activation and Epithelial Inflammation
por: Son, Minjung, et al.
Publicado: (2023)

MHY2245, a Sirtuin Inhibitor, Induces Cell Cycle Arrest and Apoptosis in HCT116 Human Colorectal Cancer Cells
por: Kang, Yong Jung, et al.
Publicado: (2022)

MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling
por: Lamichane, Shreekrishna, et al.
Publicado: (2019)

Novel SIRT Inhibitor, MHY2256, Induces Cell Cycle Arrest, Apoptosis, and Autophagic Cell Death in HCT116 Human Colorectal Cancer Cells
por: Kim, Min Jeong, et al.
Publicado: (2020)

Author Correction: Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair
por: Park, Ji Hye, et al.
Publicado: (2022)

Anti-Inflammatory Effects of the Novel Barbiturate Derivative MHY2699 in an MPTP-Induced Mouse Model of Parkinson’s Disease
por: Lee, Seulah, et al.
Publicado: (2021)

A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells
por: Richa, Sachan, et al.
Publicado: (2020)

MHY2251, a New SIRT1 Inhibitor, Induces Apoptosis via JNK/p53 Pathway in HCT116 Human Colorectal Cancer Cells
por: Kang, Yong Jung, et al.
Publicado: (2023)

MHY440, a Novel Topoisomerase Ι Inhibitor, Induces Cell Cycle Arrest and Apoptosis via a ROS-Dependent DNA Damage Signaling Pathway in AGS Human Gastric Cancer Cells
por: Jang, Jung Yoon, et al.
Publicado: (2018)

Evaluation of the Novel Synthetic Tyrosinase Inhibitor (Z)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) In Vitro and In Silico
por: Bang, EunJin, et al.
Publicado: (2018)

The mTOR–lysosome axis at the centre of ageing
por: Carosi, Julian M., et al.
Publicado: (2021)

Cytoprotective Roles of a Novel Compound, MHY-1684, against Hyperglycemia-Induced Oxidative Stress and Mitochondrial Dysfunction in Human Cardiac Progenitor Cells
por: Jang, Woong Bi, et al.
Publicado: (2018)

Autophagy termination and lysosome reformation regulated by mTOR
por: Yu, Li, et al.
Publicado: (2010)

Anti-Browning Effect of 2-Mercaptobenzo[d]imidazole Analogs with Antioxidant Activity on Freshly-Cut Apple Slices and Their Highly Potent Tyrosinase Inhibitory Activity
por: Lee, Jieun, et al.
Publicado: (2023)

Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells
por: Heo, Jang Won, et al.
Publicado: (2012)

Mesoglycan attenuates VSMC proliferation through activation of AMP-activated protein kinase and mTOR
por: Lee, Kyung Young, et al.
Publicado: (2016)

Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
por: Woo, Yu Mi, et al.
Publicado: (2015)

Correction: Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells
por: Heo, Jang Won, et al.
Publicado: (2012)

Decursin and Doxorubicin Are in Synergy for the Induction of Apoptosis via STAT3 and/or mTOR Pathways in Human Multiple Myeloma Cells
por: Jang, Jinsil, et al.
Publicado: (2013)

A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1
por: De, Umasankar, et al.
Publicado: (2015)

A New Synthetic Histone Deacetylase Inhibitor, MHY2256, Induces Apoptosis and Autophagy Cell Death in Endometrial Cancer Cells via p53 Acetylation
por: De, Umasankar, et al.
Publicado: (2018)

Activity-independent targeting of mTOR to lysosomes in primary osteoclasts
por: Wang, Andrew, et al.
Publicado: (2017)

mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance
por: Woo, Yunseo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iq4b6v8buh7i2rl7i5ugh7l5mo